Back
Lvmh Moet Hennessy Louis Vuitton SE Vs. Janux Therapeutics Industry Stock Comparison
Buy
51
LVMHF
Lvmh Moet Hennessy Louis Vuitton SE
Last Price:
644.34
Seasonality Move:
4.88%
Sell
34
JANX
Janux Therapeutics
Last Price:
66.55
Seasonality Move:
133.13%
Buy
51
Lvmh Moet Hennessy Louis Vuitton SE (LVMHF)
is a Buy
Is Lvmh Moet Hennessy Louis Vuitton SE a Buy, Sell or Hold?
- The current Lvmh Moet Hennessy Louis Vuitton SE [LVMHF] share price is $642.71. The Score for LVMHF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- LVMHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVMHF Stock Price Chart
What is Lvmh Moet Hennessy Louis Vuitton SE's stock price today?
-
The Lvmh Moet Hennessy Louis Vuitton SE share price today is $642.71
The current trend is relatively stagnant and LVMHF is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $59.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
LVMHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.05 | Sell |
| Relative Strength Index (14 RSI): | 51.52 | Buy |
| Chaikin Money Flow: | 2549 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (612.07 - 658.59) | Buy |
| Bollinger Bands (100): | (646.28 - 740) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 63.62 | Buy |
| Chaikin Money Flow: | -6955717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.07 - 55.53) | Buy |
| Bollinger Bands (100): | (41.63 - 51.75) | Buy |
LVMHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 624.01 | Buy |
| 20-day SMA: | 627.28 | Buy |
| 50-day SMA: | 670.14 | Sell |
| 200-day SMA: | 770.56 | Sell |
| 8-day EMA: | 629.33 | Buy |
| 20-day EMA: | 633.28 | Buy |
| 50-day EMA: | 658.88 | Sell |
| 200-day EMA: | 734.75 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.16 | Buy |
| 20-day SMA: | 50.4 | Buy |
| 50-day SMA: | 49.88 | Buy |
| 200-day SMA: | 44.87 | Buy |
| 8-day EMA: | 49.16 | Buy |
| 20-day EMA: | 49.72 | Buy |
| 50-day EMA: | 49.41 | Buy |
| 200-day EMA: | 41.75 | Buy |
Lvmh Moet Hennessy Louis Vuitton SE Earnings Growth & LVMHF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
Lvmh Moet Hennessy Louis Vuitton SE Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||